Blood Group ABO

Blood Group ABO Full Name

ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase

Blood Group ABO Introduction

Understanding the ABO blood group system is essential not only for safe blood transfusion but also for interpreting genetic variations that influence human health. The ABO gene encodes two closely related glycosyltransferases: α-1,3-N-acetylgalactosaminyltransferase (A transferase) and α-1,3-galactosyltransferase (B transferase). These enzymes catalyze the final step in the biosynthesis of A and B antigens on the surface of red blood cells and many epithelial tissues by modifying the H antigen precursor. The A enzyme transfers N-acetylgalactosamine, while the B enzyme transfers galactose, producing the molecular signatures that define A, B, AB, or O blood types. Because these carbohydrate antigens are widely expressed on blood cells, vascular endothelium, and mucosal tissues, variations in the ABO gene can influence not only transfusion compatibility but also host–pathogen interactions and immune recognition. For clinicians and researchers, accurate knowledge of ABO transferase function is critical for resolving blood typing discrepancies, investigating rare subtypes, and developing reliable molecular diagnostics.

Recent molecular genetics studies have revealed that subtle mutations in the ABO gene can significantly alter the catalytic activity or substrate specificity of these transferases, leading to rare blood group subtypes. For example, sequencing analyses using PCR-SBT methods have identified variants associated with the Bw subtype, where mutations in the glycosyltransferase gene modify the substrate recognition properties of the B transferase. Structural modeling further demonstrated that these amino-acid substitutions can reshape the active site conformation of the enzyme, reducing or modifying its ability to transfer galactose to the H antigen. Similarly, characterization of the Aw33 subtype uncovered a novel allele containing mutations at positions c.467C>T and c.543G>C. These variants affect the activity of the α-1,3-N-acetylgalactosaminyltransferase encoded by the A allele, resulting in weakened A antigen expression and a serologically weak A phenotype. Such discoveries highlight how even minor nucleotide changes can reshape glycosyltransferase function, producing clinically important phenotypic differences that may complicate blood typing or transfusion compatibility testing.

Beyond determining blood type, accumulating evidence shows that ABO gene variants are associated with multiple human diseases, making this locus an increasingly important biomarker in medical research. Large-scale phenome-wide association studies involving more than 1.5 million blood donors have demonstrated significant correlations between ABO blood groups and the risk of thromboembolic disorders and arterial diseases. Mechanistically, these associations are believed to involve the regulation of circulating levels of von Willebrand factor (vWF) and coagulation factor VIII, which vary according to ABO genotype and influence thrombosis susceptibility. Additional population-based genetic studies have also linked specific ABO polymorphisms, such as SNP rs529565, to an increased risk of ischemic stroke, with gene–gene interaction analyses suggesting that the combined effects of multiple vascular risk genes may further amplify disease susceptibility. Together, these findings demonstrate that the ABO locus extends far beyond its classical role in transfusion medicine; alterations in glycosyltransferase activity can influence vascular biology, coagulation pathways, and inflammatory responses, making the ABO gene a valuable target for genetic risk assessment and precision medicine research.

Alternate Names for Blood Group ABO

ABO; ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase); GTB; NAGAT; A3GALNT; A3GALT1; histo-blood group ABO system transferase; ABO weak transfer; ABO A3 transferase

• 1.Li H, et al.; Association study of polymorphisms in the ABO gene and their gene-gene interactions with ischemic stroke in Chinese population. J Clin Lab Anal. 2018, 32(4):e22329.
  2.Li S, Schooling CM. A phenome-wide association study of ABO blood groups. BMC Med. 2020, 18(1):334.